In
the April edition of i2P E-Magazine, I discussed the new clinical
pharmacy referral system (MARS-Rx...Monitoring and Referral System)
we are trialing at my workplace.
With any system of this kind the communication required to make
it work properly and effectively must be carefully planned.
For
the moment, we use the following tools for communication, after
each consultation:
* A written report to the referrer, which may detail the patient's
medication history, the problems identified with their treatment
and the recommendations arising.
We keep a copy of this report to monitor outcomes from our recommendations,
as a quality control measure.
* Comments in the patient's notes, to ensure that our recommendations
are documented officially, and are seen by prescribers and other
professionals.
* A copy of the report, with patient details removed, is published
in a regular magazine style publication. This is distributed to
leading clinicians within the region, to demonstrate what we are
capable of achieving, when we work together.
There
are many logical extensions that could be explored in the future.
Improved communication both with GPs and community pharmacists
is constantly being touted as the way of the future, but only
now are major steps being taken in most areas to achieve this.
What
we perceive as being an optimal liaison between community pharmacy
and the hospital goes along these lines:
* The patient receives a discharge summary, which lists in brief,
all their medications, dosing, brief details on side effects and
things to look out for.
They are given some counseling on this and given the chance to
ask any questions.
* We ask the patient which community pharmacy they normally go
to, and provide a copy of this summary to that pharmacy. This
enables community pharmacists to keep in touch with patient details,
and give them lead-time to prepare their own comprehensive reinforcement
counseling materials.
* A copy of the sheet is sent to the GP, who will write new prescriptions.
* The patient presents their new prescriptions at the community
pharmacy, where one of the pharmacists is familiar with their
new profile and is able to provide improved counseling.
There may also be a need for Consumer Medication Information (CMIs)
and perhaps to assess for concordance (with a view to suitability
for Webster-Paks or similar), and the possibility of a Home Medicines
Review (formerly Domiciliary Medication Management Review (DMMR))
for those who are in need.
Even though a patient may have been reviewed in the hospital,
this cannot equate to the same personal level achieved by community
pharmacists, and the focus on the issues related to taking and
storing medication in the home environment as well as a DMMR involving
a home visit from the community pharmacist.
The
current need for patient details to be transmitted by sheets of
paper could be avoided through the proposed Better Medication
Management System (BMMS).
The transfer of the patient's latest medication profile to a smart-card
or central database or other suitable electronic format, would
create efficiencies we can't really imagine at the moment.
Back
to Frontpage
|